Background
Methods
Results
Conclusions
Key Words
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryReferences
- Parkinson's disease: Insights from pathways.Hum Mol Genet. 2010; 19: R21-R27
- Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.Curr Pharm Des. 2010; 16: 2766-2778
- Mitochondrial matters of the brain: The role in Huntington's disease.J Bioenerg Biomembr. 2010; 42: 193-198
- Role of oxidative stress in the pathophysiology of bipolar disorder.Neurochem Res. 2010; 35: 1295-1301
- Redox dysregulation, neurodevelopment, and schizophrenia.Curr Opin Neurobiol. 2009; 19: 220-230
- Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.Eur J Neurosci. 2000; 12: 3721-3728
- Magnetic resonance spectroscopy studies of the antioxidant system in schizophrenia.Antioxid Redox Signal. 2011; 15: 2057-2065
- Altered glutathione redox state in schizophrenia.Dis Markers. 2006; 22: 83-93
- Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene.Am J Hum Genet. 2006; 79: 586-592
- Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence.Proc Natl Acad Sci U S A. 2007; 104: 16621-16626
- Oxidative stress in schizophrenia: Pathogenetic and therapeutic implications.Antioxid Redox Signal. 2011; 15: 1999-2002
- Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(−/−) knockout mouse: Novel model system for a severely compromised oxidative stress response.J Biol Chem. 2002; 277: 49446-49452
- Redox dysregulation affects the ventral but not dorsal hippocampus: Impairment of parvalbumin neurons, gamma oscillation, and related behaviours.J Neurosci. 2010; 30: 2547-2558
- Reverse translational approach to redox dysregulation in schizophrenia: Genetics, environment, neurodevelopment and therapy.Biol Psychiatry. 2010; 67: 199
Monin A, Klaey M, Butticaz C, Cabungcal JH, Steullet P, Do KQ (2011): Redox dysregulation affects proliferation, differentiation of oligodendrocyte progenitors and myelination: Relevance for Schizophrenia Abstract at the Viewer/Itinerary Planner, 41th Annual Meeting of the Society for Neuroscience, Washington, DC.
- Schizophrenia as a disorder of neurodevelopment.Annu Rev Neurosci. 2002; 25: 409-432
- Childhood onset schizophrenia: Support for a progressive neurodevelopmental disorder.Int J Dev Neurosci. 2010; 29: 251-258
- Measurements of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: A systematic review and methanalysis.Neuropsychology. 2005; 30: 1949-1962
- Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: A combined MRI and 1H-MRS study.Neuroimage. 2010; 53: 51-57
- Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls.Eur Psychiatry. 2011; 26: 57-63
- Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: A (1)H spectroscopy study.Schizophr Res. 2009; 115: 88-93
- Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulated, dorsolateral prefrontal cortex and thalamus.Schizophr Res. 2009; 111: 86-93
- 1H-MRS at 4 Tesla in minimally treated early schizophrenia.Mol Psychiatry. 2009; 15: 629-636
- Proton MRS in twin pairs discordant for schizophrenia.Mol Psychiatry. 2008; 15: 308-318
- 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia.Am J Psychiatry. 2004; 161: 1116-1118
- Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naïve schizophrenic patients.BMC Psychiatry. 2005; 5: 6
- Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.Neuropsychopharmacology. 2011; 36: 1781-1791
- Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).Schizophr Res. 2009; 108: 69-77
- Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not first-episode patients with schizophrenia: A proton magnetic resonance spectroscopy study.Schizophr Res. 2005; 73: 153-157
- Neurochemical changes in the rat prefrontal cortex following acute phencyclidine treatment: An in vivo localized 1H MRS study.NMR Biomed. 2009; 22: 737-744
- Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans, Psychomimetic, perceptual, cognitive, and neuroendocrine responses.Arch Gen Psychiatry. 1994; 51: 199-214
- Thinking glutamatergically: Changing concepts of schizophrenia based upon changing neurochemical models.Clin Schizophr Relat Psychoses. 2010; 4: 189-200
- Neurochemical profile of the developing mouse cortex determined by in vivo 1H NMR spectroscopy at 14 T and the effect of recurrent anesthaesia.J Neurochem. 2010; 115: 1466-1477
- N-Acetylcysteine—A safe antidote for cysteine/glutathione deficiency.Curr Opin Pharmacol. 2007; 7: 355-359
- Glutathione biosynthesis and its inhibition.Methods Enzymol. 1995; 252: 26-30
- System x(c)- and thioredoxin reductase 1 cooperatively rescue glutathione deficiency.J Biol Chem. 2010; 285: 22244-22253
- N-acetyl cysteine as a glutathione precursor for schizophrenia—a double-blind, randomized, placebo-controlled trial.Biol Psychiatry. 2008; 64: 361-368
- Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients.Neuropsychopharmacology. 2008; 33: 2187-2199
- The Handbook of Experimental Animals: The Laboratory Mouse. Academic Press, Oxford, England2008
- MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T.Magn Reson Med. 2009; 61: 1279-1285
- In vivo measurement of glycine with short echo-time 1H MRS in human brain at 7 T.MAGMA. 2008; 22: 1-4
- Toward an in vivo neurochemical profile: Quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain.J Magn Reson. 1999; 141: 104-120
- Automatic, localized in vivo adjustment of all first- and second-order shim coils.Magn Reson Med. 1993; 29: 804-811
- Field mapping without reference scan using asymmetric echo-planar techniques.Magn Reson Med. 2000; 43: 319-323
- Localized short-echo-time proton MR spectroscopy with full signal-intensity acquisition.Magn Reson Med. 2006; 56: 965-970
- Food intake, water intake, and drinking spout side preference of 28 mouse strains.Behav Genet. 2002; 32: 435-443
- Introduction to Linear Regression Analysis. 4th edition. 2006 (Chichester, England)
- Glutathione un-GLU-ed: A role for glutathione in neuronal glutamate metabolism.Abstract 225.6 Viewer/Itinerary Planner. Society for Neuroscience, San Diego, California2010
- Protection by pyruvate against glutamate neurotoxicity is mediated by astrocytes through glutathione-dependent mechanism.Mol Biol Rep. 2010; 38: 3235-3242
- Glutamate, a neurotransmitter—and so much more.Neurochem Int. 2006; 48: 416-425
- N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?.Brain Res Bull. 2010; 83: 108-121
- NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.J Neurosci. 2007; 27: 11496-11500
- Redox dysregulation and oxidative stress affect parvalbumin interneurons and neural synchrony in anterior cingulated cortex during neurodevelopment.Schizophr Bull. 2011; 37: 102
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial.Nat Med. 2007; 13: 1102-1107
- Capitalizing on extrasynaptic glutamate neurotransmission to treat antipsychotic-resistant symptoms in schizophrenia [review].Biol Psychiatry. 2008; 64: 358-360
Torres GE, Pena K, Quiroz M, Amara SG, Underhill SM (2010): Functional coupling between the glutamate transporter EAAT2 and glutamine synthetase. Abstract 544.13 Viewer/Itinerary Planner, 40th Annual Meeting of the Society for Neuroscience, San Diego, California.
- Biosynthesis of brain sphingolipids and myelin accumulation in the mouse.Lipids. 1972; 7: 656-659
- Parameters related to lipid metabolism as markers of myelination in mouse brain.J Neurochem. 2001; 76: 77-86
- Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: Therapeutic implications for Canavan disease.Brain Res Mol Brain Res. 2002; 107: 176-182
- Linking white and grey matter in schizophrenia: Oligodendrocyte and neuron pathology in the prefrontal cortex.Front Neuroanat. 2009; 3: 9
- Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell.Proc Natl Acad Sci U S A. 2000; 97: 10032-10037
- Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites.Biol Psychiatry. 2002; 52: 823-830
- Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naïve schizophrenics: A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.Arch Gen Psychiatry. 1991; 48: 563-568
- Glutamate as a marker of cognitive function in schizophrenia: A proton spectroscopic imaging study at 4 Tesla.Biol Psychiatry. 2011; 69: 19-27
- Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.Neuroimage. 2002; 17: 1638-1648
- Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease.Arch Neurol. 2002; 59: 955-962
- Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging.Mech Ageing Dev. 1997; 97: 9-14
- α-ketoglutarate dehydrogenase: A mitochondrial redox sensor.Free Radic Res. 2011; 45: 29-36
- Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confounds.J Neurosci Methods. 2008; 169: 208-213
- Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia.Schizo Res. 2009; 109: 159-166
- Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress.Mol Psychiatry. 2004; 9 (643): 684-697
- Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: Implications for the mitochondrial dysfunction hypothesis.Biol Psychiatry. 2009; 65: 489-494
- Metabolic profiling of CSF: Evidence that early intervention may impact on disease progression and outcome in schizophrenia.PLoS Med. 2006; 3: e327
- Plasma alanine levels increase in patients with schizophrenia as their clinical symptoms improve-Results from the Juntendo University Schizophrenia Projects (JUSP).Psychiatry Res. 2010; 177: 27-31
- Ontogeny of the human nervous system: What is happening when?.Early Hum Dev. 2006; 82: 257-266
- The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice.J Neurochem. 2003; 84: 1173-1183
- Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation.Hippocampus. 2008; 18: 602-609
- Birth-related genomic and transcriptional changes in mouse lung modulation by transplacental N-acetylcysteine.Mutat Res. 2003; 544: 441-449
- Taurine: New implications for an old amino acid.FEMS Microbiol Lett. 2003; 226: 195-202
Article Info
Publication History
Footnotes
Authors JMdND and AK contributed equally to this work.